Phytopharm moves forward on Cogane Phase II trial
Business Financial Newswire - Pharmaceutical development and food development company Phytopharm said progress was being made towards a Phase II clinical trial of Cogane, its Parkinson's disease treatment, following US regulatory approval.
Patient enrolment was planned to begin in late 2010 and results expected in late 2012.
http://www.bfnnews.com/display/?id=3...d=standardNews